Tarsus Pharmaceuticals, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RTW INVESTMENTS, LP | 05/15/2025 | 3.32 M | $170.34 M | 2.46% | 8.43% |
BLACKROCK, INC. | 05/02/2025 | 3.15 M | $162.01 M | -10.88% | 8.02% |
PARADIGM BIOCAPITAL ADVISORS LP | 05/15/2025 | 2.61 M | $134.09 M | 3.09% | 6.63% |
JENNISON ASSOCIATES LLC | 05/05/2025 | 2.49 M | $128.05 M | -0.30% | 6.34% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 2.45 M | $126.10 M | 8.87% | 6.24% |
VANGUARD GROUP INC | 05/09/2025 | 2.23 M | $114.38 M | 5.27% | 5.66% |
MORGAN STANLEY | 05/15/2025 | 2.01 M | $103.40 M | 2.22% | 5.12% |
TORONTO DOMINION BANK | 05/15/2025 | 1.87 M | $96.31 M | -1.81% | 4.76% |
DEEP TRACK CAPITAL, LP | 05/15/2025 | 1.48 M | $76.25 M | 100.00% | 3.77% |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. | 05/15/2025 | 1.40 M | $71.79 M | -11.97% | 3.55% |
LORD, ABBETT & CO. LLC | 05/13/2025 | 1.33 M | $68.41 M | 4.04% | 3.38% |
ASSENAGON ASSET MANAGEMENT S.A. | 04/15/2025 | 1.13 M | $57.81 M | -1.88% | 2.86% |
CITADEL ADVISORS LLC | 05/15/2025 | 992.64 K | $50.99 M | 1,151.11% | 2.52% |
STATE STREET CORP | 05/15/2025 | 910.72 K | $46.78 M | -0.67% | 2.31% |
MACQUARIE GROUP LTD | 05/15/2025 | 892.78 K | $45.86 M | 9.42% | 2.27% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 865.43 K | $44.47 M | 3.17% | 2.20% |
INVESCO LTD. | 05/12/2025 | 826.52 K | $42.46 M | -11.33% | 2.10% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 05/15/2025 | 717.85 K | $36.88 M | 100.00% | 1.82% |
ORBIMED ADVISORS LLC | 05/15/2025 | 653.74 K | $33.58 M | 100.00% | 1.66% |
ARTISAN PARTNERS LIMITED PARTNERSHIP | 05/14/2025 | 603.21 K | $30.99 M | -12.74% | 1.53% |
JANUS HENDERSON GROUP PLC | 05/15/2025 | 512.96 K | $26.52 M | 4,009.60% | 1.30% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 05/15/2025 | 510.00 K | $26.20 M | 100.00% | 1.30% |
ENSIGN PEAK ADVISORS, INC | 05/14/2025 | 487.31 K | $25.03 M | -14.52% | 1.24% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 485.02 K | $24.92 M | -20.19% | 1.23% |
PRICE T ROWE ASSOCIATES INC /MD/ | 05/14/2025 | 433.17 K | $22.25 M | -5.99% | 1.10% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 429.14 K | $22.05 M | 27.02% | 1.09% |
GILDER GAGNON HOWE & CO LLC | 05/15/2025 | 416.81 K | $21.41 M | 3.11% | 1.06% |
D. E. SHAW & CO., INC. | 05/15/2025 | 410.68 K | $21.10 M | 12.35% | 1.04% |
CORMORANT ASSET MANAGEMENT, LP | 05/15/2025 | 400.00 K | $20.55 M | -20.00% | 1.02% |
NORTHERN TRUST CORP | 05/13/2025 | 363.43 K | $18.67 M | 1.63% | 0.92% |
DIMENSIONAL FUND ADVISORS LP | 05/13/2025 | 308.23 K | $15.83 M | -9.69% | 0.78% |
GOLDMAN SACHS GROUP INC | 06/27/2025 | 301.51 K | $15.49 M | -5.40% | 0.77% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 290.32 K | $14.91 M | -1.15% | 0.74% |
05/12/2025 | 264.52 K | $13.59 M | 100.00% | 0.67% | |
MILLENNIUM MANAGEMENT LLC | 05/15/2025 | 247.20 K | $12.70 M | -61.62% | 0.63% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 246.84 K | $12.68 M | 151.89% | 0.63% |
CUTTER CAPITAL MANAGEMENT, LP | 05/15/2025 | 205.00 K | $10.53 M | 82.22% | 0.52% |
INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 05/15/2025 | 200.00 K | $10.27 M | -42.86% | 0.51% |
TFG ASSET MANAGEMENT GP LTD | 05/15/2025 | 178.47 K | $9.17 M | -10.77% | 0.45% |
SANDS CAPITAL VENTURES, LLC | 05/14/2025 | 170.00 K | $8.73 M | 0.00% | 0.43% |
ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 04/24/2025 | 168.72 K | $8.67 M | -6.85% | 0.43% |
DEUTSCHE BANK AG\ | 05/09/2025 | 151.42 K | $7.78 M | -1.32% | 0.38% |
ATIKA CAPITAL MANAGEMENT LLC | 05/14/2025 | 144.40 K | $7.42 M | -18.51% | 0.37% |
J. GOLDMAN & CO LP | 05/15/2025 | 140.29 K | $7.21 M | 7.75% | 0.36% |
RUSSELL INVESTMENTS GROUP, LTD. | 05/13/2025 | 134.62 K | $6.92 M | 6,112.14% | 0.34% |
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC | 05/09/2025 | 130.29 K | $6.69 M | 0.15% | 0.33% |
ALLY BRIDGE GROUP (NY) LLC | 05/15/2025 | 127.93 K | $6.57 M | -26.11% | 0.33% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 121.27 K | $6.23 M | -22.46% | 0.31% |
PRUDENTIAL FINANCIAL INC | 05/13/2025 | 120.81 K | $6.21 M | -18.78% | 0.31% |
WELLINGTON MANAGEMENT GROUP LLP | 05/13/2025 | 116.11 K | $5.96 M | -15.12% | 0.30% |
Tarsus Pharmaceuticals, Inc. institutional Ownership - FAQ's
During the previous two years, 214 institutional investors and hedge funds held shares of Tarsus Pharmaceuticals, Inc.. The most heavily invested institutionals were:
RTW INVESTMENTS, LP: 3.32 M
BlackRock, Inc.: 3.15 M
Paradigm Biocapital Advisors LP: 2.61 M
JENNISON ASSOCIATES LLC: 2.49 M
TANG CAPITAL MANAGEMENT LLC: 2.45 M
VANGUARD GROUP INC: 2.23 M
109.69% of Tarsus Pharmaceuticals, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 48.09 M shares in the last 24 months. This purchase volume represents approximately $1.98 B in transactions.